Orzyme-Plus Tablet is a combination pharmaceutical formulation containing Pancreatin (175 mg), Simethicone (50 mg), and Charcoal (50 mg), designed to aid digestive health and alleviate gastrointestinal discomfort. Pancreatin, a mixture of digestive enzymes including amylase, lipase, and protease, facilitates the breakdown of carbohydrates, fats, and proteins, thereby improving nutrient absorption in patients with pancreatic insufficiency or digestive enzyme deficiencies. Simethicone acts as an anti-foaming agent that reduces bloating and discomfort caused by excessive gas accumulation in the gastrointestinal tract by coalescing gas bubbles, promoting their easier expulsion. Activated Charcoal serves as an adsorbent, binding toxins, gases, and other harmful substances within the gut, thereby reducing flatulence and intestinal gas-related symptoms. Orzyme-Plus is indicated for the management of indigestion, dyspepsia, flatulence, and other functional gastrointestinal disturbances associated with enzyme insufficiency or gas retention. The tablet should be administered as directed by a healthcare professional, typically after meals to optimize enzymatic activity and symptomatic relief. Caution is advised in patients with known hypersensitivity to any component, and it is contraindicated in cases of intestinal obstruction or acute pancreatitis. Adverse effects are generally minimal but may include mild gastrointestinal upset. This combination offers a comprehensive approach to digestive support by addressing enzyme deficiency, gas reduction, and toxin adsorption simultaneously.